39 research outputs found

    Suppression of low-density lipoprotein oxidation, vascular smooth muscle cell proliferation and migration by a herbal extract of Radix Astragali, Radix Codonopsis and Cortex Lycii

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Atherosclerosis is a major cause of death in developed world. Atherosclerosis is characterized by low-density lipoprotein deposition in the arterial wall which ultimately begets the formation of lesions. Rupture of lesions finally leads to clinical events such as heart attack and stroke. Atherosclerosis is a complication associated with diabetes. In patients with diabetes, the risk of atherosclerosis is three to five folds greater than in non-diabetics. Our previous study showed that a herbal extract of <it>Radix Astragali, Radix Codonopsis </it>and <it>Cortex Lycii</it>, namely SR10, could improve glucose homeostasis both <it>in vitro </it>and <it>in vivo</it>. In this study, we want to further investigate the efficacy of SR10 in treating atherosclerosis.</p> <p>Method</p> <p>The inhibitory effect of SR10 on low-density lipoprotein oxidation was investigated using free radical-induced erythrocyte hemolysis model and copper ion-induced low-density lipoprotein oxidation model. Since vascular smooth muscle cell proliferation and migration are important processes in atherogenesis, we also examined the effect of SR10 in inhibiting these events.</p> <p>Results</p> <p>Our results showed that SR10 inhibited erythrocyte hemolysis with IC<sub>50 </sub>value at 0.25 mg/ml and significantly prolonged low-density lipoprotein oxidation <it>in vitro</it>. SR10 attenuated platelet derived growth factor-BB-induced vascular smooth muscle cell proliferation by promoting cell cycle arrest at G<sub>0</sub>/G<sub>1 </sub>phase as well as inhibiting vascular smooth muscle cell migration.</p> <p>Conclusion</p> <p>The potential application of SR10 in treating atherosclerosis has been implied in this study. Animal model will be needed to further verify the efficacy of SR10 in future.</p

    Hypnotika und Sedativa

    No full text
    TREND: AuffĂ€lligste Entwicklung bei den Schlafmitteln ist der seit 25 Jahren zu beobachtende starke VerordnungsrĂŒckgang um 80 %. Die RĂŒckgĂ€nge betrugen im vergangenen Jahr bei den Benzodiazepinen wiederum ĂŒber 10 % und bei den Benzodiazepinagonisten Zolpidem und Zopiclon 4 %. Die Verordnungen von Melatonin haben wiederum sehr deutlich zugenommen. Pflanzliche Hypnotika sind nur noch mit einem homöopathischen PrĂ€parat vertreten. BEWERTUNG: Die Umschichtung zu den kurzwirksamen Z-Substanzen ist durch ihre selektivere hypnotische Wirkung und das vermutlich geringere AbhĂ€ngigkeitspotenzial gerechtfertigt. Insgesamt zeigen die Zahlen, dass nur ein Bruchteil der Patienten mit Schlafstörungen Hypnotika verordnet bekommt. Nach neueren Metaanalysen sind verhaltenstherapeutische Verfahren wirksam und insgesamt der Behandlung mit Hypnotika ĂŒberlegen

    Modulation of the Coagulation System During Severe Streptococcal Disease.

    No full text
    Haemostasis is maintained by a tightly regulated coagulation system that comprises platelets, procoagulant proteins, and anticoagulant proteins. During the local and systemic response to bacterial infection, the coagulation system becomes activated, and contributes to the pathophysiological response to infection. The significant human pathogen, Streptococcus pyogenes has multiple strategies to modulate coagulation. This can range from systemic activation of the intrinsic and extrinsic pathway of coagulation to local stimulation of fibrinolysis. Such diverse effects on this host system imply a finely tuned host-bacteria interaction. The molecular mechanisms that underlie this modulation of the coagulation system are discussed in this review
    corecore